Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo
Antimicrobial Agents and Chemotherapy · 05.11.2025 · 69 (11)
DOI: 10.1128/aac.00492-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.11.2025. Verfasst von Elizabeth A Wynn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genes, Environment and Health, National Jewish Health, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Linezolid, Diarylquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Veterans Affairs, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
A key challenge in preclinical tuberculosis drug development is identifying optimal antibiotic combinations. Drug interactions are complex because one drug may affect Mycobacterium tuberculosis ( Mtb ) physiology in a way that alters the activity of another drug. Conventional pharmacodynamic evaluation based on colony-forming units (CFU) does not provide information about this physiologic interaction because CFU enumerates bacteria but does not give information about the drug’s effect on bacterial cellular processes. SEARCH-TB is a novel pharmacodynamic (PD) approach that uses targeted in vivo transcriptional profiling to evaluate drug effects on Mtb physiology. To evaluate SEARCH-TB’s capacity to elucidate drug interactions, we deconstructed the BPaL (bedaquiline, pretomanid, and linezolid) regimen in the BALB/c high-dose aerosol mouse infection model, measuring the effect of 2-, 7-, and 14-day treatment with drugs in monotherapy, pairwise combinations, and as a three-drug combination. Monotherapy induced drug-specific Mtb transcriptional responses by day 2 with continued evolution over 14 days. Bedaquiline dominated pairwise combinations with pretomanid and linezolid, whereas the pretomanid-linezolid combination induced a transcriptional profile intermediate between either drug. In the three-drug BPaL regimen, adding both pretomanid and linezolid to bedaquiline yielded a greater transcriptional response than expected, based on pairwise results. This work demonstrates that physiologic perturbations induced by a single drug may be modified in complex ways when drugs are combined. This establishes proof of concept that SEARCH-TB provides a highly granular readout of drug interactions in vivo, providing information distinct from CFU burden and suggesting a future where regimen selection is informed by in vivo molecular measures of Mtb physiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genes, Environment and Health, National Jewish Health, Denver, Colorado, USA.
- Rocky Mountain Regional VA Medical Center, Aurora, Colorado, USA.
- Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.
- Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Elizabeth A Wynn, Jo Hendrix, Michael A Lyons, Gregory T Robertson, Nicholas D Walter
Förderung
- Veterans Affairs
- NIAID NIH HHS
- NIH HHS
- BLRD VA
- Bill and Melinda Gates Foundation
- Gates Foundation
- National Institutes of Health
Zitieren
APA
Wynn, E. A., Dide-Agossou, C., Al Mubarak, R., Rossmassler, K., Hendrix, J., Voskuil, M. I., Obregón-Henao, A., Lyons, M. A., Robertson, G. T., Moore, C. M., & Walter, N. D. (2025). Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. Antimicrobial Agents and Chemotherapy, 69(11). https://doi.org/10.1128/aac.00492-25
Vancouver
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Hendrix J, Voskuil MI, et al. Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. Antimicrobial Agents and Chemotherapy. 2025;69(11). doi:10.1128/aac.00492-25
BibTeX
@article{Wynn2025,
author = {Wynn, Elizabeth A and Dide-Agossou, Christian and Al Mubarak, Reem and Rossmassler, Karen and Hendrix, Jo and Voskuil, Martin I and Obregón-Henao, Andrés and Lyons, Michael A and Robertson, Gregory T and Moore, Camille M and Walter, Nicholas D},
title = {Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {11},
doi = {10.1128/aac.00492-25}
}
EUVIMED